A Prospective, First in Human Study to Evaluate the Safety and Performance of a Flow Modification System
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Enrollment
10
The surgical implant for ED treatment
The surgical implant for ED treatment
Primary Safety Endpoint • 30-day Freedom from Major Adverse Events
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.